MM

Mannohar Medhak

Active Director Director DIN 09002247
DIN 09002247 First appointment Dec 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value •••• Premium profile

About Mannohar Medhak

Data last updated:

Mannohar Medhak is a Director at Airon Pharma Solutions Private Limited (since 2020). The company operates in Healthcare. Airon Pharma Solutions Private Limited reported revenue of ₹1.1 Lakh (FY 2021).

DIN 09002247
Primary Designation Director
Industry Healthcare
First Appointment 18 Dec 2020
Oldest Company Age 5 yrs
Largest company Airon Pharma Solutions Private Limited · ₹1.1 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Dec 20202020₹1.1 Lakh (FY 2021)Active

Board colleagues of Mannohar Medhak

Directorship timeline

Open interactive timeline →
Airon Pharma Solutions Private Limited
Premium access

Shareholding and investment profile for Mannohar Medhak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mannohar Medhak

Mannohar Medhak currently holds 1 directorship: Airon Pharma Solutions Private Limited (Director, since 18 Dec 2020, revenue ₹1.1 Lakh (FY 2021)).

Mannohar Medhak was first appointed on 18 Dec 2020 as Director at Airon Pharma Solutions Private Limited.

The current boards of Mannohar Medhak's companies include Thiroomala Rathnamm Srinivasan (Airon Pharma Solutions Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available